321 related articles for article (PubMed ID: 20623546)
1. Resveratrol: Biological and pharmaceutical properties as anticancer molecule.
Hsieh TC; Wu JM
Biofactors; 2010; 36(5):360-9. PubMed ID: 20623546
[TBL] [Abstract][Full Text] [Related]
2. The anticancer effects of resveratrol: modulation of transcription factors.
Whitlock NC; Baek SJ
Nutr Cancer; 2012; 64(4):493-502. PubMed ID: 22482424
[TBL] [Abstract][Full Text] [Related]
3. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.
Gusman J; Malonne H; Atassi G
Carcinogenesis; 2001 Aug; 22(8):1111-7. PubMed ID: 11470738
[TBL] [Abstract][Full Text] [Related]
4. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.
Fulda S; Debatin KM
Cancer Res; 2004 Jan; 64(1):337-46. PubMed ID: 14729643
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
Hsieh TC
Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.
Delmas D; Lançon A; Colin D; Jannin B; Latruffe N
Curr Drug Targets; 2006 Apr; 7(4):423-42. PubMed ID: 16611030
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
Cal C; Garban H; Jazirehi A; Yeh C; Mizutani Y; Bonavida B
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):77-93. PubMed ID: 12678904
[TBL] [Abstract][Full Text] [Related]
8. [Resveratrol--evaluation of anticancer activity].
Szumiło J
Pol Merkur Lekarski; 2006 Mar; 20(117):362-4. PubMed ID: 16780276
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms.
Sinha D; Sarkar N; Biswas J; Bishayee A
Semin Cancer Biol; 2016 Oct; 40-41():209-232. PubMed ID: 26774195
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol and cellular mechanisms of cancer prevention.
Shukla Y; Singh R
Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol and breast cancer risk.
Levi F; Pasche C; Lucchini F; Ghidoni R; Ferraroni M; La Vecchia C
Eur J Cancer Prev; 2005 Apr; 14(2):139-42. PubMed ID: 15785317
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol.
Pervaiz S
Drug Resist Updat; 2004 Dec; 7(6):333-44. PubMed ID: 15790544
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells.
Clément MV; Hirpara JL; Chawdhury SH; Pervaiz S
Blood; 1998 Aug; 92(3):996-1002. PubMed ID: 9680369
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review.
Fulda S; Debatin KM
Cancer Detect Prev; 2006; 30(3):217-23. PubMed ID: 16872757
[TBL] [Abstract][Full Text] [Related]
15. Phytochemicals in cancer prevention and therapy: truth or dare?
Russo M; Spagnuolo C; Tedesco I; Russo GL
Toxins (Basel); 2010 Apr; 2(4):517-51. PubMed ID: 22069598
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol from red grapes - pedestrian polyphenol or useful anticancer agent?
Gescher AJ
Planta Med; 2008 Oct; 74(13):1651-5. PubMed ID: 18446674
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells.
Cai JB; Zhang ZH; Xu DJ; Qian ZY; Wang ZR; Huang YZ; Zou JG; Cao KJ
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1419-25. PubMed ID: 18671725
[TBL] [Abstract][Full Text] [Related]
18. Fighting cancer with red wine? Molecular mechanisms of resveratrol.
Kraft TE; Parisotto D; Schempp C; Efferth T
Crit Rev Food Sci Nutr; 2009 Oct; 49(9):782-99. PubMed ID: 20443159
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M
Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol: a review of preclinical studies for human cancer prevention.
Athar M; Back JH; Tang X; Kim KH; Kopelovich L; Bickers DR; Kim AL
Toxicol Appl Pharmacol; 2007 Nov; 224(3):274-83. PubMed ID: 17306316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
